THE DEAL, AT A GLANCE
From the announcementOuter Bio
01Who is involvedBacked by CEO Michael Polansky, board member Stefani Germanotta (Lady Gaga), Outer Bio develops Yuna, an ex vivo human-skin tissue platformFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedOuter Bio raised $23M Series BFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersOuter Bio is positioning Yuna as an AI-driven ex vivo human-skin tissue platform for dermatology and bioactive discovery after emerging from stealth with approximately…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Outer Bio · Financing Record
Explore source-linked visual explanations for Outer Bio. Unsupported claims are withheld while source review continues.
Record 11287 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →